(redirected from Botulinum Neurotoxin)
BoNTBotulinum Neurotoxin
BoNTBroadband Optical Network Termination
References in periodicals archive ?
The pain-reducing effect of a single injection of Botulinum neurotoxin peaked at 10 days, then decreased up to 14 days.
Botulinum neurotoxin for management of intractable central leakage through a voice prosthesis in surgical voice restoration.
Gordon urges that you consult an experienced cosmetic dermatologist if considering botulinum neurotoxin and/or dermal fillers.
botulinum neurotoxin -specific primers with almost equal melting temperatures (60[degrees]C) for the simultaneous detection of C.
Limitations associated with the current mouse LD50 assay, which has been the standard for potency and stability testing of BOTOX[R] and BOTOX[R] Cosmetic and other botulinum neurotoxin type A products, include the necessary involvement of animals due to the current structure of the assay, the complexity of the procedures involved, lack of specificity, as well as variability between assays and laboratories.
Botulinum neurotoxins are classified into 7 types, A-G.
The new cell-based potency assay for BOTOX and BOTOX Cosmetic is specific to Allergan's formulation of botulinum neurotoxin type A.
Bonti's lead product candidate, EB-001, is a botulinum neurotoxin serotype E (BoNT/E).
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Assessment: Botulinum neurotoxin in the treatment of autonomic dis-orders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
We have demonstrated for the first time that a single, intranasal vaccination of an adenovirus-based vector encoding a humanized HC 50 of BoNT/C can provide full protection in vaccinated mice against botulinum neurotoxin type C," Zeng said.
botulinum comprises a heterogenous group of subspecies that produce botulinum neurotoxin (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2).